GeneDx Holdings Corp. Ratios

Ratios Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 42.20%2.25%-7.82%-11.40%44.43%63.64%
EBT Margin -15.14%-134.58%-115.64%-254.81%-87.23%-17.23%
EBIT Margin -15.50%-134.95%-210.25%-284.48%-89.15%-7.60%
EBITDA Margin -15.14%-134.58%-115.64%-233.91%-86.56%-16.99%
Operating Margin -15.50%-134.95%-210.25%-284.48%-89.15%-7.60%
Net Margin -16.69%-134.58%-115.64%-233.89%-86.77%-17.12%
FCF Margin -15.62%-65.37%-95.11%-139.04%-91.52%-11.13%
Efficiency
Inventory Average 29.21M23.56M11.22M9.71M
Assets Average 402.87M522.52M454.85M419.07M
Equity Average 29.03M320.90M240.86M236.63M
Invested Capital -319.05M399.10M260.00M234.32M251.05M
Asset Utilization Ratio 0.530.450.450.73
Leverage & Solvency
Interest Coverage Ratio -38.84-97.81-157.37-208.19
Debt to Equity -0.060.040.040.230.21
Debt Ratio 0.080.020.020.130.12
Equity Ratio -1.310.700.520.540.58
Times Interest Earned -38.84-97.81-157.37-208.19
Valuation
Enterprise Value 3,342.55M675.46M-21.90M-58.97M1,970.27M
Market Capitalization 3,097.46M1,076.03M102.04M71.18M2,111.45M
Return Ratios
Return on Sales -0.15%-1.35%-1.16%-2.34%-0.87%-0.17%
Return on Capital Employed -1.48%-1.77%-0.46%-0.06%
Return on Invested Capital -1.86%-0.73%-0.10%
Return on Assets -0.61%-1.05%-0.39%-0.12%
Return on Equity -8.45%-1.71%-0.73%-0.22%